To our knowledge, thyroid cancer incidence is increasing faster than any other cancer type and is currently the fifth most common cancer among women. While this rise is likely multifactorial, there has been scarce consideration of the effect of insurance statuses on the treatment of thyroid cancer.
T he incidence of thyroid cancer has been increasing by 5% each year over the last decade. 1, 2 By 2019, it is projected to be the third most common cancer among women younger than 45 years. 1, 2 While there has been an increase in the incidence rate of thyroid cancer, 5-year survival remains above 98%. [1] [2] [3] As life expectancy and the incidence of thyroid cancer rises in the United States, the management and treatment of survivors of thyroid cancer may have a significant economic burden on the US healthcare system. [1] [2] [3] [4] An estimated $1.6 billion has been cumulatively spent on the treatment of thyroid cancer care since 1985. 5 Forty-one percent of those costs were attributed to diagnosis, surgery, and adjuvant therapy for new thyroid cancer cases and 27% were attributed to the surveillance of survivors. While the rise in thyroid cancer incidence is likely multifactorial, including the possibility of overdiagnosis, to our knowledge there have been few research studies investigating how insurance expansion influences the diagnosis and treatment of thyroid cancer. In 2006, Massachusetts passed health care reform legislation that expanded Medicaid, created new subsidized insurance programs for those ineligible for Medicaid, and extended young adult eligibility on parental plans until the age of 26 years. 6, 7 Since then, Massachusetts has seen increased coverage to more than 97% of residents, with most newly insured people enrolling in either Medicaid or the newly created, subsidized Commonwealth Care insurance (eFigure 1 in the Supplement). 7 Nonwhite residents had particularly striking gains in coverage, with uninsured rates among black and Hispanic residents decreasing from approximately 18% to fewer than 5% (eFigure 2 in the Supplement). 7, 8 Previous studies
found that this expansion is associated with the increased use of discretionary and acute surgical procedures and increased rates of undergoing resection for other malignancies. 9- 13 The
Massachusetts legislation was a framework for the Affordable Care Act, which has provided an estimated 16.9 million Americans insurance coverage. 14 To our knowledge, the effect of insurance expansion on the surgical treatment of thyroid cancer has not been investigated. We evaluated the association of insurance expansion with thyroid cancer treatment using the 2006 Massachusetts health reform, which serves as a unique natural experiment for the potential implications of the Affordable Care Act. We hypothesized that insurance expansion was associated with increased rates of surgical treatment among patients with government-subsidized and selfpay (GSSP) insurance in Massachusetts compared with those in control states. Additionally, we hypothesized that nonwhite patients, who disproportionately gained coverage, had greater increases in undergoing treatment compared with white patients.
Methods

Study Design and Data
We identified a cohort of 56 581 inpatient admissions using the 15 We included all nondisabled, nonelderly adult patients with thyroid cancer and all patients who were uninsured or had coverage through Medicaid or Commonwealth Care (available in Massachusetts after 2006). This cohort, referred to as GSSP patients, is the primary group that was affected by the reform in Massachusetts or by similar reforms in control states. Sensitivity analyses were performed on privately insured (PI) patients to evaluate for secular trends within Massachusetts. Consistent with previously published studies, admissions of patients with diagnoses of thyroid cancer were determined using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes. 5, 16 Patients younger than 18 years and patients who were 65 years or older were excluded from the primary analysis, as the Massachusetts law did not directly affect these populations. Patients with Medicare coverage were also excluded from the analysis, as the 2006 law was not intended to affect Medicare eligibility or benefits. The study was deemed exempt from institutional review board approval because it was a retrospective review using a database that did not have patient-specific data.
Outcomes
The primary outcome of the study was partial or total thyroidectomy for thyroid cancer treatment. 
Risk Adjustment
Multivariable analyses were performed controlling for patient and system-level factors including patient age, sex, race/ ethnicity, comorbidities using the Elixhauser Comorbidity Index, hospital type, and secular trends. 17 Race/ethnicity was
Key Points
Question How does insurance expansion affect the rate of thyroidectomy for treating thyroid cancer?
Findings In this study using difference-in-differences models, the 2006 Massachusetts health care reform was associated with a 26% increased rate of thyroidectomy for treating thyroid cancer and a 21% increased rate of neck dissection among patients with cancer compared with control states.
Meaning In Massachusetts, the expansion of health care results in an increased treatment of thyroid cancer.
included as a covariate in analyses examining changes in outcomes for all GSSP patients. To evaluate differential changes by race, cohorts were stratified as being either white or nonwhite (black or Hispanic). Hospital type was classified as either a privately owned hospital with any number of beds or location, not-for-profit rural hospitals with any number of beds, not-for-profit urban hospitals with fewer than 300 beds, and not-for-profit urban hospitals with more than 300 beds. Additional analyses, including hospital-level annual volume of thyroidectomies, did not significantly change our results. For each model we used the Stata-derived cluster-correlated robust estimate of variance to account for clustering within hospitals. 18 We controlled for secular trends using a continu- 
Statistical Analysis
Our primary analyses used difference-in-differences models to evaluate differential changes in outcomes among GSSP patients in Massachusetts as compared with those in control states. [20] [21] [22] Difference-in-differences models identify changes in outcomes in a group exposed to a policy change compared with an unexposed control group. We used a tripleinteraction term between Massachusetts, GSSP, and a postreform variable to evaluate for any differential change in Massachusetts after the implementation of reform compared with concurrent trends in control states. This triple-interaction term accounts for not only changes for GSSP in control states but also among PI patients in Massachusetts. The subsequent coefficient represents the independent change in outcomes for GSSP in Massachusetts attributable to the 2006 reform. We used Poisson regression models to evaluate surgical interventions as count data and to estimate the incident rate ratio (IRR) of undergoing thyroidectomy or neck dissections for thyroid cancer. The primary dependent variables in these models were thyroidectomy or neck dissection. The population denominators for GSSP and PI patients were determined using data available through the US Census Bureau. 23 In the final riskadjusted models, the IRR represents the independent effect of the 2006 insurance expansion on thyroidectomy or neck dissection rates among GSSP patients in Massachusetts.
To evaluate changes in thyroidectomy and neck dissections for cancer treatment by the race/ethnicity of patients, we stratified GSSP patients by race/ethnicity and used a 2-way interaction term between Massachusetts and the postreform period. Population denominators were determined using US Census Bureau data. 23 Additional models using a 3-way interaction term between Massachusetts, the postreform period, and nonwhite race/ethnicity did not change our results. Data were analyzed using Stata software, version 14 (StataCorp). All results were considered significant at P ≤ .05.
Results
Our cohort included 8534 admissions of patients with thyroid cancer in Massachusetts and 48 047 admissions in control states ( Table 1) . Patients in Massachusetts were similar to those in control states in terms of age, sex, and comorbidities. However, patients in Massachusetts were more likely to be white and less likely to be admitted to private hospitals. Before the reform, there was no differential trend in undergoing a thyroidectomy between Massachusetts and control states among either GSSP (IRR, 1.01; 95% CI, 0.99-1.03; P =.18)orPI patients (IRR, 1.00; 95% CI, 1.00-1.01; P = .33) (Figure 1) . Similarly, there was no differential preexpansion trend in undergoing a neck dissection between Massachusetts and control states among GSSP (IRR, 1.00; 95% CI, 0.99-1.02; P =. 7 4)or PI patients (IRR, 1.00; 95% CI 0.99-1.01; P = .65) (eFigure 3 in the Supplement). The Massachusetts coverage expansion was associated with a 26% increased rate of undergoing a thyroidectomy (IRR, 1.26; 95% CI, 1.04-1.52; P = .02) and a 22% increased rate of undergoing a neck dissection (IRR, 1.22; 95% CI, 1.07-1.37; Abbreviation: NFP, not-for-profit.
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Insurance Expansion and Surgical Management of Thyroid Cancer P = .002) among GSSP patients in Massachusetts ( Examining these trends further by race/ethnicity, we found that insurance expansion had a particularly strong association with rates of undergoing procedures for nonwhite patients. Before the reform, nonwhite and white patients had comparable rates of undergoing a thyroidectomy in Massachusetts and control states ( Figure 2 ). Stratified analyses found that the 2006 reform was associated with a 68% increased rate of undergoing a thyroidectomy (IRR = 1.68; 95% CI, 1.24-2.29; P=.001) among nonwhite patients in Massachusetts compared with concurrent trends among patients in control states ( Table 3) . White patients in Massachusetts had an increased rate of undergoing a thyroidectomy that was not statistically significant (IRR, 1.22; 95% CI, 0.98-1.51; P = .07). Similarly, nonwhite and white patients had similar rates of undergoing a neck dissection in Massachusetts and control states before the reform (eFigure 4 in the Supplement). Analogous to thyroidectomy, the Massachusetts coverage expansion was associated with a 45% increased rate of undergoing neck dissections (IRR, 1.45; 95% CI, 1.12-1.87; P = .01) among nonwhite patients compared with control states (Table 3 ). There was a nonsignificant increase (IRR, 1.16; 95% CI, 0.99-1.40; P = .07) in the rate of undergoing a neck dissection for white patients in Massachusetts compared with the trend in control states. Sensitivity analyses using the triple-interaction term between Massachusetts, nonwhite race/ethnicity, and the postreform period confirmed that the expansion was associated with a statistically greater increased rate of undergoing a thyroidectomy (IRR, 1.66; 95% CI, 1.23-2.24; P = .001) and neck dissection (IRR, 1.44; 95% CI, 1.13-1.86; P = .004) among nonwhite patients in Massachusetts.
Discussion
The incidence of thyroid cancer continues to rise across the country and considerable disparities in diagnosis, management, and outcomes have been documented. Simultaneously, there is growing attention to the potential overdiagnosis and treatments for thyroid cancer. To our knowledge, our study is the first to evaluate the influence of insurance expansion on surgical procedures for thyroid cancer. We found that the Massachusetts insurance expansion was associated with a 26% increased rate of thyroidectomy and a 22% increased rate of neck dissections for thyroid cancer. The increased rate occurred disproportionately among nonwhite patients, with a 68% increased rate of undergoing a thyroidectomy and 45% increased rate of undergoing neck dissections among nonwhite patients compared with control states.
Although no studies to date to our knowledge have evaluated the effect of health care expansion on the diagnosis and treatment of thyroid cancer, several studies evaluating other medical conditions have suggested that increased insurance coverage is associated with the increased use of services. [24] [25] [26] Early reports on insurance expansion through the Affordable Care Act similarly report an increased use of services among patients after gaining insurance coverage. 27 The findings in this study are consistent with our previous work showing a strong association between the 2006 Massachusetts reform and increased use of surgical services, especially among nonwhite populations.
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Our findings suggest that expanded insurance coverage has contributed to increased diagnoses and interventions on thyroid cancer, most likely because of an increased access to care. Patients may be presenting more readily to primary care clinicians and may be referred at a higher rate to specialists who are more likely to intervene. While there are certainly benefits to expanding health insurance coverage, including the diagnosis and treatment of cancer, there must also be thoughtful consideration to the appropriateness of diagnostic and treatment modalities.
Increasing attention is being directed toward the most efficient and effective methods of managing thyroid cancer. Previous reports suggest that the overdiagnosis of small, papillary thyroid carcinoma accounts for a significant portion of the rising incidence of thyroid cancer. 1, 3, 28, 29 However, the increased incident rate of these small cancers predates this study and is unlikely to have influenced our findings selectively for GSSP patients in Massachusetts. The data used in this study do not provide adequate oncologic granularity to determine pathologic diagnoses, stages of disease, or long-term outcomes. Therefore, it remains unclear whether increased intervention, as seen after the insurance expansion in Massachusetts, will necessarily translate into improved morbidity and prognosis. The present study was not designed to explicitly examine the appropriateness of thyroidectomy for cancer. Despite a disproportionate increase in thyroidectomy for cancer after insurance expansion, GSSP patients in Massachusetts still had lower resection rates than privately insured patients in the state (eFigure 5 in the Supplement). However, we cannot determine whether this gap in thyroidectomy rates represents a persistent disparity in care for GSSP patients, an overuse of surgery among PI patients, or some combination of the two. The increased rates in Massachusetts, however, provide important insights into potential changes to insurance expansion elsewhere in the country.
Limitations
We acknowledge several important limitations. First, the State Inpatient Databases are composed of administrative data that are susceptible to coding errors. However, Healthcare Cost and Utilization Project data have been used extensively in prior studies evaluating thyroid cancer.
5,30-32 Furthermore, it is unlikely that coding discrepancies would selectively and directionally lead to increased rates of thyroidectomy and neck dissections among GSSP patients in Massachusetts without concordant changes among PI patients. Using the State Inpatient Databases, we are unfortunately unable to identify the specific individuals that gained insurance after the Massachusetts reform. We included a much broader population of individuals who were potentially affected by insurance expansion before and after the reform in both Massachusetts and Finally, Massachusetts was a unique health care environment even before the 2006 reform, with small uninsured populations and a high concentration of health care professionals. Thus, the Massachusetts experience may not be generalizable elsewhere in the country. An evaluation of parallel trends before the reform reveals similar rates and trends between Massachusetts and control states before the expansion. Other factors independent of insurance expansion, such as changes in the number of trained or practicing endocrine surgeons in Massachusetts, could also have influenced rates after the reform. However, our evaluation of trends among PI patients in Massachusetts, who were less directly affected by the 2006 reform, showed no significant change in outcomes after implementation. Collectively, these findings argue against alternative factors between states or within Massachusetts driving the increased receipt of thyroidectomy and neck dissections for thyroid cancer among GSSP patients after insurance expansion. Nonetheless, given the unique aspects of Massachusetts, the control states used in this study may not fully represent the counterfactual of Massachusetts without reform. While we are unable to fully overcome these limitations with the data available, ongoing evaluation of states expanding insurance coverage through the Affordable Care Act will provide much greater insights. As 19 remaining states consider whether to expand Medicaid as a part of the Affordable Care Act, our findings provide important information about how such an expansion may influence care delivery for thyroid cancer. Policy makers, researchers, and health systems should continue to critically analyze the effects of ongoing policy changes on the accessibility and equity of clinical care.
Conclusions
In this study, we report that the 2006 Massachusetts insurance expansion was associated with significant increases in surgical intervention for thyroid cancer, specifically among nonwhite populations. Our findings provide encouraging evidence that insurance coverage may help mitigate racial or socioeconomic disparities while also raising questions concerning the relative appropriateness of the observed management of thyroid cancer, which deserves additional investigation. 
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